Selected Clients

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.



The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization of Novartis. With approximately 5,000 scientists and physicians around the world, NIBR research is focused on discovering innovative new drugs that will change the practice of medicine.



Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.



Since its founding in 1947, Dana-Farber has been committed to providing cancer patients with the best treatment available today while developing tomorrow's cures through cutting-edge research.



LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence.



Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing.



An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases – from inflammatory diseases to cancer – based on the company’s proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent is a privately held company based in Cambridge, Massachusetts, Cequent was established in 2006.



BioScience Communications is the medical communications company for personal attention with a global reach. Bioscience Communications ensures that scientific value and messages are delivered as compelling strategies and educational programs through the hands-on dedication of senior-level staff.

Referrals

"Cequent Pharmaceuticals needed bioinformatics expertise that was cost-effective and timely. Entagen provided us with exceptional service, fast turnaround and great results. This enabled our research team to gain further insights into platform development. We highly recommend Entagen."

- Jens Harborth, Ph.D.
Associate Director
Cequent Pharmaceuticals

“BioScience called on Entagen to assist in a scientific visualization project and we were extremely pleased with the result. Their work was thoughtful and innovative, and their execution was very timely.”

- Stacey George
Vice President
Washington, DC